GLUCOTRACK, INC.

GCTK ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2019 FY2018 FY2017 FY2016 FY2015 FY2014
Revenue $208.0K $43.5K $589.5K $611.7K $143.2K $59.8K
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $1.6M $3.0M $3.2M $2.9M $2.3M $1.8M
SG&A Expense $1.5M $2.5M $1.5M $1.1M $1.1M $230.8K
Operating Income $3.5M $-6.5M $10.6M $-5.7M $-4.7M $-3.6M
Operating Margin 1,685.6% -15,035.4% 1,794.2% -924.6% -3,251.7% -6,034.9%
Interest Expense $15.2K $-2.2K
Pretax Income $-3.5M $-6.7M $-10.3M $-5.4M $-5.8M $3.0M
Income Tax Expense
Net Income $3.5M $-6.7M $10.3M $-5.4M $-5.8M $3.0M
Net Margin 1,690.4% -15,442.0% 1,752.2% -884.4% -4,080.7% 4,986.1%
EPS (Basic) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EPS (Diluted) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 17.51B 17.08B 12.78B 11.77B 11.14B 10.79B
Shares Outstanding (Diluted) 17.51B 17.08B 12.78B 11.77B 11.14B 10.88B
Dividends Per Share